Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
CBAK Energy Technology Q4 2025 and FY2025 Earnings Call - 40135/32140 Capacity Ramp Sparks Revenue Surge but Squeezes Margins
CBAK spent 2025 reshaping its product mix and capacity footprint, and the results are mixed, fast and messy. Management is racing new 40135 and 32140 production lines into service to meet demand that ...
- Q4 consolidated net revenue reported at $58.80 million, up 131.8% year over year.
- Management provided conflicting full-year top-line figures on the call, with the CEO stating consolidated net revenue of $100.19 million while the CFO reported $195.19 million; the discrepancy also appears in Hitrans figures.
- Hitrans raw-materials segment reported a sharp rebound, management saying it surged 123% year over year; CEO cited $89.21 million for Hitrans while the CFO cited $188.92 million, underscoring the reporting inconsistency that requires clarification.
- +16 more takeaways
PubMatic Q4 2025 Earnings Call - Agentic AI adoption accelerates, setting up H2 2026 double-digit growth
PubMatic reported a strong Q4 that beat guidance on revenue and adjusted EBITDA, with Q4 adjusted EBITDA of $27.8 million, a 35% margin, and free cash flow up 32% year over year. The quarter was drive...
- Q4 beat: revenue and adjusted EBITDA exceeded guidance, with Q4 adjusted EBITDA of $27.8 million, representing a 35% margin.
- Agentic AI is front and center: PubMatic says agentic advertising is an incremental tailwind, and the company has already run over 250 agentic deals.
- Early agentic performance claims include a pilot delivering more than 5x cost efficiencies, 87% faster campaign setup, and 70% faster issue resolution.
- +11 more takeaways
EverCommerce Fourth Quarter 2025 Earnings Call - AI-First Push: EverHealth Scribe and ZyraTalk to Reaccelerate Growth
EverCommerce closed Q4 with steady top-line and a loud strategic pivot: revenue of $151.2 million (up 5.2% y/y) and adjusted EBITDA of $44.2 million (29.2% margin), while management doubled down on an...
- Q4 reported revenue $151.2 million, up 5.2% year-over-year; subscription and transaction revenue $144.1 million for the quarter.
- Pro forma LTM revenue $591.7 million, a 6.4% year-over-year increase; LTM adjusted EBITDA margin 30.7%.
- Q4 adjusted EBITDA $44.2 million, a 29.2% margin; management says margin expanded about 470 basis points since 2023.
- +15 more takeaways
Puma Biotechnology Q4 2025 Earnings Call - Nerlynx revenue rises but Q4 inventory build and rising gross-to-net pressure; alisertib trials show accelerated enrollment with Q2 2026 interim readouts
Puma closed Q4 2025 with top-line momentum for NERLYNX, reporting $75.5 million in total revenue and $59.9 million in net product revenue, helped by a seasonal inventory build and stronger specialty d...
- Total revenue for Q4 2025 was $75.5 million, including net product revenue of $59.9 million and royalty revenue of $15.6 million.
- Gross revenue from NERLYNX sales in Q4 was $82.9 million, with net product revenue up versus Q3 2025 ($51.9 million to $59.9 million) and versus Q4 2024 ($54.4 million to $59.9 million).
- NERLYNX ex-factory bottle sales were 3,298 in Q4 2025, up approximately 12% quarter-over-quarter and 11% year-over-year; inventory is estimated to have increased by ~343 bottles in Q4.
- +15 more takeaways
Crexendo Q4 2025 Earnings Call - Accretive ESI Acquisition Accelerates Path to $100M Revenue Run-Rate
Crexendo closed 2025 with double-digit organic growth, sustained GAAP profitability, and a strategic acquisition intended to push the company toward a $100 million revenue run-rate. Management reporte...
- Full-year 2025 revenue $68.2M, up 12% year-over-year, with Q4 revenue $18.1M, up 11% year-over-year.
- GAAP net income for 2025 $5.1M, non-GAAP net income $11.4M, marking the 10th consecutive GAAP profitable quarter and 29th consecutive non-GAAP profitable quarter.
- Cash and cash equivalents finished the year at $31.4M, up from $18.2M, with cash from operations $9.3M and non-GAAP free cash flow $9.3M for the year.
- +12 more takeaways
BioCryst Pharmaceuticals 4Q 2025 Earnings Call - ORLADEYO momentum fuels profit while navenibart aims to lock HAE prophylaxis decision
BioCryst closed 2025 with clear commercial traction and a tidy operating story. ORLADEYO delivered $601.8 million in revenue, up 38% year over year and 43% excluding the European business sold in Octo...
- ORLADEYO posted $601.8 million in 2025 revenue, up 38% year over year and 43% when excluding the European business sold in October 2025.
- Management is emphasizing profitability and disciplined capital allocation under new CEO Charlie Gayer, who called BioCryst a focused, profitable rare disease company.
- BioCryst stripped out its European ORLADEYO business, which was loss making, improving base margins and simplifying the commercial footprint.
- +12 more takeaways
Blend Labs, Inc Q4 2025 Earnings Call - Debuts Autopilot agent as company returns to profitability and ups buyback
Blend closed Q4 2025 showing a lean, cash-positive profile and a strategic pivot toward agentic AI. Revenue was $32.4 million with $5.4 million in non-GAAP operating income, positive free cash flow fo...
- Q4 revenue $32.4 million, non-GAAP operating income $5.4 million, non-GAAP operating margin 17%.
- Mortgage Suite revenue $18.8 million, up 3% year-over-year; funded loan volume grew 11% in Q4; Economic Value per Funded Loan (EVPFL) was $83.
- Consumer Banking Suite revenue $11.5 million, up 21% year-over-year but down 10% sequentially due to one large customer churn and home equity seasonality.
- +12 more takeaways
Cheniere Energy Fourth Quarter and Full Year 2025 Earnings Call - Upsized $10B Buyback After Early Completion of 2020 Plan and >95% Contracted Platform
Cheniere closed 2025 with record volumes, strong cash generation and accelerated execution on both operations and capital allocation. The company reported Q4 consolidated adjusted EBITDA of about $2.0...
- Q4 consolidated adjusted EBITDA approximately $2.0 billion; full-year 2025 adjusted EBITDA about $6.94 billion, at the high end of guidance.
- Distributable cash flow roughly $1.5 billion in Q4 and about $5.3 billion for the full year, about $100 million above the high end of guidance.
- Record 2025 production: 670 cargoes, over 46 million tons; Q4 exported 185 cargoes, up 22 versus Q3 driven by Stage 3 volumes and improved reliability.
- +12 more takeaways
GeoPark Limited 4Q 2025 Earnings Call - Transformational Frontera deal and Vaca Muerta ramp reposition company for scale by 2028
GeoPark closed 2025 with stabilizing Colombian production and an early Argentina contribution, hitting or beating full-year guidance despite a weaker oil price. Production averaged 28,233 boepd in 202...
- Transformational M&A: GeoPark announced an agreed acquisition of Frontera’s Colombian upstream assets in January, which doubles its reserve base and brings pro forma net production of ~40,000 boepd, materially boosting scale and cash flow durability.
- Pro forma upside to 2028: Management says the Frontera deal plus current plans could push company production to exceed 90,000 boepd by 2028 and pro forma Adjusted EBITDA near $950 million, versus standalone targets of 44,000-46,000 boepd and $490-$520 million Adjusted EBITDA by 2028.
- Vaca Muerta entry is live: GeoPark closed Loma Jarillosa Este and Puesto Silva Oeste blocks in October, started workovers and will mobilize a Nabors rig in early March to drill a five-well pad, targeting an Argentina exit rate of 5,000-6,000 boepd in 2026 and a 20,000 boepd plateau by 2028.
- +11 more takeaways
Origin Materials Q4 2025 Earnings Call - PET cap progress meets tests, but cash runway only into Q3 2026
Origin reported tangible product progress this quarter, delivering a new PET cap iteration to roughly 30 prospects and achieving internal test improvements on seal performance, impact resistance, and ...
- New PET cap iteration was delivered this month to about 30 prospective customers, incorporating customer feedback and showing marked improvements in internal seal and impact tests.
- Origin claims its PET caps meet industry benchmarks for pressurized water applications on ball impact and heat stress testing, and performed comparably to HDPE caps in a live retail pilot with Power Hydration.
- Customer qualification remains the choke point, taking longer than Origin had modeled, driven by bespoke testing requirements and unfamiliarity with a PET cap geometry versus HDPE.
- +9 more takeaways